Showing results (151-160 of 187) with videos related to
Sort By:
Pageof 19
Eclinicalmedicine|February 9, 2026
Solvent-based or nab-paclitaxel plus ramucirumab for pretreated gastric cancer with peritoneal dissemination and prespecified biomarker analysis (P-SELECT/WJOG10617G): a randomised phase 2 trial in JapanKenro Hirata, Yasuo Hamamoto, Hirokazu Shoji, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 31, 2024
Phase II Study of the Liposomal Formulation of Eribulin (E7389-LF) in Combination with Nivolumab: Results from the Gastric Cancer CohortAkihito Kawazoe, Noboru Yamamoto, Naotoshi Sugimoto, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 6, 2013
Randomized, open-label, phase III study comparing irinotecan with paclitaxel in patients with advanced gastric cancer without severe peritoneal metastasis after failure of prior combination chemotherapy using fluoropyrimidine plus platinum: WJOG 4007 trialShuichi Hironaka, Shinya Ueda, Hirofumi Yasui, et al.Cancer Science|June 30, 2019
Sex differences in the safety of S-1 plus oxaliplatin and S-1 plus cisplatin for patients with metastatic gastric cancerYasuhide Yamada, Wasaburo Koizumi, Kazuhiro Nishikawa, et al.Cancers|February 11, 2023
Utility of Comprehensive Genomic Profiling Tests for Patients with Incurable Pancreatic Cancer in Clinical PracticeTakuo Yamai, Kenji Ikezawa, Naotoshi Sugimoto, et al.Cancer Science|September 15, 2019
Exploration of potential prognostic biomarkers in aflibercept plus FOLFIRI in Japanese patients with metastatic colorectal cancerTetsuya Hamaguchi, Tadamichi Denda, Toshihiro Kudo, et al.Journal of Gastrointestinal Cancer|April 10, 2023
Efficacy of Pembrolizumab Monotherapy in Japanese Patients with Advanced Gastric or Gastroesophageal Junction CancerKei Muro, Kohei Shitara, Kensei Yamaguchi, et al.Clinical Colorectal Cancer|September 3, 2018
Relationship Between Thymidine Kinase 1 Expression and Trifluridine/Tipiracil Therapy in Refractory Metastatic Colorectal Cancer: A Pooled Analysis of 2 Randomized Clinical TrialsTakayuki Yoshino, Kentaro Yamazaki, Eiji Shinozaki, et al.The Lancet. Oncology|September 22, 2014
Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trialHansjochen Wilke, Kei Muro, Eric Van Cutsem, et al.Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|October 18, 2015
Efficacy and safety of S-1 and oxaliplatin combination therapy in elderly patients with advanced gastric cancerHideaki Bando, Yasuhide Yamada, Satoshi Tanabe, et al.Pageof 19